New Session: ‘Suspendilicious: Unveiling the Marvels of Lipid Suspensions’


Kristof Kimpe
Research & Development, PDMS
Janssen

The title of Kristof’s presentation is ‘Suspendilicious: Unveiling the Marvels of Lipid Suspensions’.

It will discuss on the pre-clinical oral dosing of suspensions of solid dispersions and the pre-clinical oral dosing of suspensions of salts of very weak bases.

Dr. Kristof Kimpe obtained a master degree in chemistry at the university of Leuven in 1999 and received his Ph.D. in chemistry in 2003 at the same university. He joined Janssen Pharmaceutica in 2005 and assumed global, end-to-end responsibility for excipients. In 2016 Dr. Kimpe joined the preformulation group of the pharmaceutical sciences department, supporting drug product development all the way from pre-clinical to commercial formulations.

Find out more about the sessions at the Global DDF Summit in the agenda.

Commercial Partners: